Post-thrombotic syndrome (PTS) is a condition that can develop in about half of the patients with deep vein thrombosis (DVT) of lower limbs. In the present study, we evaluated the expression of inflammatory biomarkers in the early phases of DVT and their correlation with the onset of PTS. Patients were enrolled after the first episode of DVT and were followed up for 1, 4, 8, 12 and 18 months. At each visit, blood sample was collected to evaluate plasma levels of matrix metalloproteinase (MMP)-1,-2,-3,-7,-8 and -9 MMP inhibitors, TIMP-1,-2, neutrophil gelatinase-associated lipocalin (NGAL) and cytokines TNF-α and IL-6. Analysis included 201 patients [86 males (42⋅79%) and 115 females (57⋅21%); average age 56±7 years]. Of the 201 patients, 47 (23⋅38%; 21 males, 26 females) developed PTS during the follow-up period. The control group was made up of 60 individuals without DVT (22 males and 38 females). High plasma levels of MMPs, NGAL and cytokines were recorded during the acute phase after DVT. Moreover, patients with PTS showed higher levels of MMP-1 and MMP-8 with respect to patients without PTS. There is a close relationship between DVT, the individual risk of PTS and specific biomarkers such as MMPs and other related molecules, which may help guide prevention and therapy based on the patient’s individual risk profile, and has to be studied in future.

Plasma MMP and TIMP evaluation in patients with deep venous thrombosis. Could they have a predictive role in the development of post-thrombotic syndrome? / De Franciscis, S.; Gallelli, L.; Amato, B.; Butrico, L.; Rossi, A.; Buffone, G.; Calio, F. G.; De Caridi, G.; Grande, R.; Serra, R.. - In: INTERNATIONAL WOUND JOURNAL. - ISSN 1742-4801. - 13:6(2016), pp. 1237-1245. [10.1111/iwj.12489]

Plasma MMP and TIMP evaluation in patients with deep venous thrombosis. Could they have a predictive role in the development of post-thrombotic syndrome?

Butrico L.;Grande R.;
2016

Abstract

Post-thrombotic syndrome (PTS) is a condition that can develop in about half of the patients with deep vein thrombosis (DVT) of lower limbs. In the present study, we evaluated the expression of inflammatory biomarkers in the early phases of DVT and their correlation with the onset of PTS. Patients were enrolled after the first episode of DVT and were followed up for 1, 4, 8, 12 and 18 months. At each visit, blood sample was collected to evaluate plasma levels of matrix metalloproteinase (MMP)-1,-2,-3,-7,-8 and -9 MMP inhibitors, TIMP-1,-2, neutrophil gelatinase-associated lipocalin (NGAL) and cytokines TNF-α and IL-6. Analysis included 201 patients [86 males (42⋅79%) and 115 females (57⋅21%); average age 56±7 years]. Of the 201 patients, 47 (23⋅38%; 21 males, 26 females) developed PTS during the follow-up period. The control group was made up of 60 individuals without DVT (22 males and 38 females). High plasma levels of MMPs, NGAL and cytokines were recorded during the acute phase after DVT. Moreover, patients with PTS showed higher levels of MMP-1 and MMP-8 with respect to patients without PTS. There is a close relationship between DVT, the individual risk of PTS and specific biomarkers such as MMPs and other related molecules, which may help guide prevention and therapy based on the patient’s individual risk profile, and has to be studied in future.
2016
Cytokines; Deep vein thrombosis; Matrix metalloproteinases; Post-thrombotic syndrome; Post-thrombotic ulceration; Analysis of Variance; Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Male; Matrix Metalloproteinases; Middle Aged; Multivariate Analysis; Postthrombotic Syndrome; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index; Tissue Inhibitor of Metalloproteinase-1; Venous Thrombosis
01 Pubblicazione su rivista::01a Articolo in rivista
Plasma MMP and TIMP evaluation in patients with deep venous thrombosis. Could they have a predictive role in the development of post-thrombotic syndrome? / De Franciscis, S.; Gallelli, L.; Amato, B.; Butrico, L.; Rossi, A.; Buffone, G.; Calio, F. G.; De Caridi, G.; Grande, R.; Serra, R.. - In: INTERNATIONAL WOUND JOURNAL. - ISSN 1742-4801. - 13:6(2016), pp. 1237-1245. [10.1111/iwj.12489]
File allegati a questo prodotto
File Dimensione Formato  
De-Franciscis_Plasma MMP-TIMP_2016.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 500.74 kB
Formato Adobe PDF
500.74 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1283276
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 26
social impact